Ahn J.E., Karlsson M.O., Dunne A., Ludden T.M. Likelihood based approaches to handling data below the quantification limit using NONMEM VI. Journal of Pharmacokinetics and Pharmacodynamics. 2008 Aug;35(4):401-21.

Beal, S.L. , Sheiner, L.B., Boeckmann, A., & Bauer, R.J. NONMEM User’s Guides. (1989-2009), Icon Development Solutions, Ellicott City, MD, USA, 2009.

Beal, S.L Ways to Fit a PK Model with Some Data Below the Quantification Limit Journal of Pharmacokinetics and Pharmacodynamics volume 28, pages481–504(2001)

Amy Cheung, Predictive QT project, DDMODEL 0000093, 2015, (repository.ddmore.eu/model/DDMODEL00000093).

Finn Norring Christensen, Flemming Yssing Hansen and Helle Bechgaard Physical interpretation of parameters in the Rosin-Rammler-Sperling-Weibull distribution for drug release from controlled release dosage forms Journal of Pharmacy and Pharmacology, Volume 32, Issue 1, September 1980, pp 580-582

J. E. Dennis, Jnr. and R. B. Schnabel Numerical Methods for Unconstrained Optimization and Nonlinear Equations Society for Industrial and Applied Mathematics ISBN-10: 0898713641

Eva Germovsek, Population PK model for gentamicin, DDMODEL 0000238, 2017, (repository.ddmore.eu/model/DDMODEL00000238).

P. Girard, Simultaneous ocular adverse event and dropout model of pimasertib, DDMODEL 0000215, 2012, (repository.ddmore.eu/model/DDMODEL00000215).

Kajsa Harling Population PK of gentamicin in cancer patients with time-varying covariates, DDMODEL 0000061, 2015, (repository.ddmore.eu/model/DDMODEL00000061).

N. H. Holford, A size standard for pharmacokinetics. Clin Pharmacokinet. 1996 May; 30(5):329-32.

Karlsson MO and Sheiner LB The importance of modeling interoccasion variability in population pharmacokinetic analyses. J Pharmacokinet Biopharm. 1993 Dec; 21(6):735-50.

L Lindstrom, M & Bates, Mark. (1990). Nonlinear Mixed Effects Models for Repeated Measures Data. Biometrics. 46. 673-87. 10.2307/2532087.

Russell B. Millar Maximum Likelihood Estimation and Inference - With Examples in R, SAS, and ADMB John Wiley & Sons, 2011

D. R. Mould and R. N. Upton Basic Concepts in population Modeling, Simulation, and Model-Based drug development CPT Pharmacometrics Syst Pharmacol. 2012 Sep; 1(9): e6.

D. R. Mould and R. N. Upton Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods. CPT Pharmacometrics Syst Pharmacol. 2013 Apr 17; 2: e38.

J. Nocedal and S. Wright Numerical Optimization Springer ISBN-10: 0387303030

Vladimir K. Piotrovskii The use of Weibull distribution to describe thein vivo absorption kinetics Journal of Pharmacokinetics and Biopharmaceutics, Volume 15, Issue 6, December 1987, pp 681–686

M. J. D. Powell The BOBYQA algorithm for bound constrained optimization without derivatives Report No. DAMTP 2009/NA06, Centre for Mathematical Sciences, Cambridge, UK.

Radhakrishnan, Krishnan & C. Hindmarsh, Alan. (1994). Description and Use of LSODE, the Livermore Solver for Ordinary Differential Equations.

M. Rowland and T. N. Tozer Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications Lippincott Williams & Wilkins, 2012

Sheiner L.B., Beal S.L. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. J. Pharmacokinet. Biopharm 86553–571.1980

R. N. Upton and D. R. Mould Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development: Part 3—Introduction to Pharmacodynamic Modeling Methods CPT Pharmacometrics Syst Pharmacol. 2014 Jan; 3(1): e88.

Wang, Yaning. (2007). Derivation of various NONMEM estimation methods. Journal of pharmacokinetics and pharmacodynamics. 35. 249. 10.1007/s10928-008-9083-7.